(UroToday.com) The 2025 ESMO annual meeting featured a biomarker-based personalization in metastatic prostate cancer session and a presentation by Dr. Alice Bernard-Tessier discussing targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback